HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Cerity Partners LLC

Cerity Partners LLC grew its stake in HealthEquity, Inc. (NASDAQ:HQY) by 15.1% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 17,259 shares of the company’s stock after buying an additional 2,258 shares during the quarter. Cerity Partners LLC’s holdings in HealthEquity were worth $1,413,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the business. Clearbridge Investments LLC increased its holdings in shares of HealthEquity by 1.9% during the 2nd quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after buying an additional 43,491 shares during the last quarter. Mackenzie Financial Corp boosted its stake in HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of HealthEquity by 8.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company’s stock valued at $133,377,000 after purchasing an additional 115,841 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of HealthEquity by 0.8% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,122,057 shares of the company’s stock valued at $96,721,000 after purchasing an additional 9,125 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in HealthEquity by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock valued at $86,909,000 after purchasing an additional 14,532 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Down 0.3 %

Shares of HealthEquity stock opened at $101.39 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The firm has a market capitalization of $8.85 billion, a price-to-earnings ratio of 84.49, a PEG ratio of 1.59 and a beta of 0.55. The stock has a 50 day moving average of $90.61 and a 200 day moving average of $83.02. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $105.82.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, research analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HQY shares. Deutsche Bank Aktiengesellschaft upped their price target on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday. JMP Securities reissued a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Bank of America boosted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $108.38.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares in the company, valued at $387,093.98. The trade was a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock valued at $884,517 over the last quarter. Insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.